In 1996, Dana-Farber/Partners CancerCare joined together three previously separate fellowship training programs at Massachusetts General Hospital Cancer Center, Dana-Farber Cancer Institute, and Brigham and Women's Hospital to create the combined Dana-Farber/Partners CancerCare Hematology/Oncology Fellowship Program. The goal of the training program is to develop academically oriented physicians who will become future leaders in clinical and laboratory investigation and clinical teaching.
The Dana-Farber/Partners CancerCare Hematology/Oncology Training Program has quickly become one of the most highly sought after and selective fellowship programs in the nation. Approximately 240 physicians complete applications for 14 available fellowships. The high caliber of the program is reflected in its fellows: all complete top residency programs, a significant percentage have doctoral degrees, and many have received major grants from organizations such as the Howard Hughes Medical Institute, the American Society of Clinical Oncologists, and the National Institutes of Health.
In the first year of the combined program, the 14 fellows have primary responsibility for patient care, working as members of a team that also includes more senior physicians. The fellows are divided into two groups, with each group spending six months in advanced clinical training at Massachusetts General Hospital Cancer Center and six months at the Dana-Farber/Brigham and Women's Cancer Center, with exposure to each center’s 12 multidisciplinary treatment programs.
During the second year, fellows begin to conduct laboratory or clinical research while continuing to care for patients. Those who decide to pursue both hematology and medical oncology, rather than specializing in either one or the other, continue their fellowship for a third year.
All applications for this program are now processed through the Electronic Residency Application Service (ERAS).
To begin the process, please visit: www.aamc.org/audienceeras.htm.
Please note that this program is listed under Brigham and Women's Hospital in ERAS. The deadline for applications is August 31, 2012.
- Completed applications will be evaluated by members of the Selection Committee
- Certain candidates will then be invited for an interview. Interviews take place in September and October, 2012.
- At the time of an applicant's visit, he/she will meet with faculty and trainees at both the Massachusetts General Hospital Cancer Center and Dana-Farber/Brigham and Women’s Cancer Center, will receive a tour of both facilities, and will meet with a group of current fellows at the end of the interview day.
Contact InformationDana-Farber/Partners CancerCare Hematology/Oncology Fellowship Program
Kim Bremner, Fellowship Coordinator